Rossor M N, Newman S, Frackowiak R S, Lantos P, Kennedy A M
Dementia Research Group, St. Mary's Hospital, London, United Kingdom.
Ann N Y Acad Sci. 1993 Sep 24;695:198-202. doi: 10.1111/j.1749-6632.1993.tb23052.x.
Early onset Familial Alzheimer's Disease (FAD) is an autosomal dominant disease with apparent complete penetrance. It is genetically heterogeneous with some families carrying mutations in the amyloid precursor protein (APP) gene which segregate with the disease. In addition, there is allelic heterogeneity with four mutations associated with FAD. Three mutations have been reported at APP 717, just distal to the C-terminus of the beta-amyloid domain, APP 717 val-ile, APP 717 val-phe, and APP 717 val-gly, which are associated with autopsy-proven Alzheimer's disease (AD). APP 670/671 lies at the N terminus of the beta-amyloid domain and is associated with clinically diagnosed FAD in two Swedish families. FAD tends to have prominent myoclonus and this is shared by the cases with APP mutations. In two unrelated UK families with APP 717 val-ile mutations there was early prominent memory impairment with dyscalculia proceeding to generalized cognitive impairment with a lack of insight. There was a late development of a gait disturbance with extrapyramidal features in some members. Positron emission tomography (PET) with fluorodeoxyglucose demonstrated posterior bitemporal biparietal hypometabolism in one case. Magnetic resonance imaging (MRI) showed generalized cerebral atrophy particularly affecting the temporal lobes and hippocampus. At autopsy, a single case showed extensive beta-amyloid deposition with congophilic angiopathy and widespread senile plaques and neurofibrillary tangles. The cytoskeletal pathology associated with abnormally phosphorylated tau was similar to cases of sporadic AD. In addition, there were widespread cortical and subcortical Lewy bodies. A single family with the APP 717 val-gly mutation also showed prominent myoclonus, lack of insight, and seizures, PET, in a single case, showed classical biparietal bitemporal hypometabolism. Autopsy, in a single case, showed diffuse deposits of beta-amyloid throughout the cortex with frequent neuritic plaques and neurofibrillary tangles. No other inclusion bodies were seen. There was severe congophilic angiopathy. The age at onset of APP mutations is around 50 years of age by contrast to other early onset FAD pedigrees.
早发性家族性阿尔茨海默病(FAD)是一种常染色体显性疾病,具有明显的完全外显率。它在遗传上具有异质性,一些家族携带淀粉样前体蛋白(APP)基因突变,这些突变与该疾病共分离。此外,存在等位基因异质性,有四种与FAD相关的突变。已报道在APP 717(位于β-淀粉样蛋白结构域C末端远端)有三种突变,即APP 717 val-ile、APP 717 val-phe和APP 717 val-gly,它们与经尸检证实的阿尔茨海默病(AD)相关。APP 670/671位于β-淀粉样蛋白结构域的N末端,与两个瑞典家族中临床诊断的FAD相关。FAD往往有明显的肌阵挛,APP突变的病例也有此表现。在两个携带APP 717 val-ile突变的不相关英国家族中,早期有明显的记忆障碍和计算障碍,随后发展为全面的认知障碍且缺乏洞察力。一些家族成员后期出现伴有锥体外系特征的步态障碍。一例患者经氟脱氧葡萄糖正电子发射断层扫描(PET)显示双侧颞叶后部和双侧顶叶代谢减低。磁共振成像(MRI)显示全脑萎缩,尤其累及颞叶和海马体。尸检时,一例患者显示广泛的β-淀粉样蛋白沉积、嗜刚果红血管病、广泛的老年斑和神经原纤维缠结。与异常磷酸化tau相关的细胞骨架病理与散发性AD病例相似。此外,还有广泛的皮质和皮质下路易小体。一个携带APP 717 val-gly突变的家族也有明显的肌阵挛、缺乏洞察力和癫痫发作,一例患者的PET显示典型的双侧顶叶和双侧颞叶代谢减低。尸检时,一例患者显示整个皮质有弥漫性β-淀粉样蛋白沉积,伴有频繁的神经炎斑和神经原纤维缠结。未见其他包涵体。有严重的嗜刚果红血管病。与其他早发性FAD家系相比,APP突变的发病年龄约为50岁。